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Introduction
The development, implementation and maintenance
of computer-executable clinical guidelines delivered
within point-of-care decision-support systems is a
multifaceted, resource-intensive process. From a know-
ledge perspective, these processes may be thought 
of as: knowledge acquisition, knowledge encoding,
guideline execution (making knowledge available to
clinicians) and knowledge base maintenance. In
practice, the usual pattern is that a guideline develop-
ment group will produce a clinical guideline and this
is used as the source for encoding into a computer-
interpretable guideline. This is then executable within
a decision-support system available to the clinician.
Guideline maintenance is necessary to incorporate
new evidence into the knowledge base.
This model of production generates a series of
problems and challenges at each step in the process.
For example, traditional guideline development –
which may be only the first step in this process – is in
itself very complex.1 So is the encoding process –
Tierney et al. describe the difficulty of encoding just
one guideline.2 Guideline execution requires the
integration of the guideline knowledge with the
clinical computer system via an ‘execution engine’.
Guideline maintenance consists of identification of
changes in evidence for recommendations, their incorp-
oration into the knowledge base, external validation
and release of guideline to the end-user.
There are some fundamental requirements in order
to deploy this approach in clinical practice. The goal
of the original guideline development is ultimately to
influence patient outcomes through changes in clinical
practice.1 To be realised, the original recommendations
constructed by the guideline author need to be faith-
fully maintained throughout the knowledge transfer
and relayed to the end-user. In addition, the process
must be scalable to enable wide-scale roll-out. A major
contributor to scalability is knowledge sharing and/or
re-use. This is often hampered because each part of
the process requires different sets of skills and so
consequently is carried out in disparate organisations
or parts of an organisation. Duplication of effort, both
within and between organisations, is often an inevit-
able consequence.3 This has led to many initiatives to
address knowledge sharing and system interoperability,
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ABSTRACT
The development, implementation and mainten-
ance of computer-executable clinical guidelines
encompass a series of complex processes. As they
are often performed by more than one organisation,
this introduces further complexity. Within the
PRODIGY project we attempt to control as many
aspects of the process as possible, in order to increase
the likelihood of achieving success. To illustrate the
complexity of the process and many of the inherent
problems and solutions, this paper describes the
evolution of the PRODIGY knowledge base,
describing the steps from acquiring knowledge,
through encoding, to the execution of guidelines, and
‘closing the loop’ by discussing an approach to know-
ledge re-use. We will also consider some of the wider
implications of our work and propose directions for
future research and development activities.
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as demonstrated by Greenes et al.’s work on GLIF
(Guideline Interchange Format).4 The ever-increasing
number of formalisms that are developed to represent
knowledge also contribute to the problem.5
PRODIGY is a major national programme of work
to create, deliver and implement guideline-based
point-of-care decision support to primary care
physicians.6 It is being developed at the Sowerby
Centre for Health Informatics at Newcastle (SCHIN).
Within the centre, all aspects of the guideline
production process are controlled, bringing together
knowledge authors, technical authors, software pro-
grammers, evaluators and disseminators to develop
the knowledge base, the software requirements spe-
cification (SRS) and an execution engine. The know-
ledge authors, working within an annual budget of
£1.3 million, are a large multidisciplinary team of clin-
icians, pharmacists, technical authors and researchers.
The product that is currently available in United
Kingdom (UK) general practices contains 131 indi-
vidual guidance topics, covering over 350 individual
scenarios (distinct types of presentation of patient or
condition).7 It is implemented on ten different sys-
tems covering over 90% of the market. The current
research phase (Phase 3) of PRODIGY is developing
methods for improving the management of chronic
disease in primary care.
This paper describes the evolution of the PRODIGY
knowledge base. It addresses some of the challenges of
guideline encoding, discusses the requirements for
representing knowledge in two different PRODIGY
models, and proposes future research and develop-
ment activities in this area.
The PRODIGY knowledge base
and guidance model
The PRODIGY knowledge base currently spans two
models – Release 1 and Phase 3 (Release 2).
Release 1
The structure of the Release 1 model can be seen in
Figure 1.8 Each level of the model contains further
information. The ‘guidance’ level – guidance are indi-
vidual topics such as asthma, sore throat, dyspepsia –
contains a series of text fields such as ‘Background
information’ or ‘Management issues’, each of which
contains information relevant to the entire guideline.
At the level of the scenario similarly – a scenario is an
easily recognisable patient state for a particular
diagnosis, for instance, ‘angina on triple therapy’, or
‘hypertensive on non-pharmacological treatment’ –
there are supportive texts, this time relating only to
the scenario. Each scenario contains ‘therapy groups’
(these are broad groupings of therapies, usually drugs,
grouped by drug class or by some other common
property of the prescriptions contained within, for
example, dose frequency). Each therapy group con-
tains prescriptions. Additionally, patient information
leaflets (PILs) are available within each scenario.
PRODIGY integrates with the electronic patient
record (EPR) so that patient data items such as age
or sex will filter out certain guidelines and/or scenarios
so that the information that is displayed to the user is
specific to the patient. Each guidance is also coded
with a set of clinical codes (4-byte or Version 2 Read
code or Clinical Terms Version 3) to allow appropriate
guidance to be ‘triggered’ when a clinical term is
recorded during the doctor/patient interaction. Once
the guidance has been triggered, the clinician has
options to access supporting texts (as described) or to
proceed to select therapy options and/or PILs. The
encounter ends with the issue of a prescription, the
issue of a PIL, or simply with advice or reassurance in
the usual manner.
Release 2
During the next design phase (Phase 3), the structure
of PRODIGY Release 1 was analysed for inclusion in
the new model. The primary reason for developing
Release 2 was to support the management of chronic
disease in primary care more effectively. To achieve
this, we incorporate the ability of the system to
‘remember’ its previous status throughout a series of
consultations over time. This means that the clinician
does not have to manually position their patient in the
guideline each time the patient attends. The system







can predict the future position of the patient in the
guideline based on actions that are taken at each suc-
cessive encounter. Other key features are: structuring
the knowledge base so that it interacts more closely
with the EPR (for example, being cognisant of
co-morbidities and co-prescribing) and to enable
‘ordinary’ clinicians to construct the guideline.
PRODIGY Release 2 is built as an ontology using
Protégé, a frame-based knowledge-authoring environ-
ment.9 A set of classes is constructed representing 
the knowledge to be acquired. A diagramming facility
allows the author to visualise spatial relationships
between guideline elements and to visualise the
guideline globally. The structure of Release 2 is again
constructed around scenarios.10 The design of scenarios
has to take into account the fact that the criteria 
for the scenario being true must be computable (for
example, the presence of a drug or other data item).
This precludes the possibility of having scenarios built
on concepts that cannot (will not) be represented 
in the patient record. This was not a requirement in
Release 1. Scenarios are linked together by action steps
(see Figure 2).
The action that is performed determines the next
scenario. ‘Consultation’ actions (history taking, inves-
tigations, referral, and PILs) are offered independently
of the scenario. Supportive texts are provided in the
form of ‘quick-helps’, background reference docu-
ments, and as ‘context-sensitive help’ from individual
actions. A state transition diagram (see Figure 3) –
which maps out the guideline – is constructed for
each condition. This also allows access to each
element that contains further levels of detail.
We have also created a PRODIGY drug dictionary
in which each product is identified with a clinical drug
term (Read code) and mapped to two proprietary
drug dictionaries to enable implementation in UK
primary care (Release 1 only uses Read codes).
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Figure 3 State transition diagram in Protégé
Knowledge acquisition 
and encoding
During Phase 3, clinical and technical authors collab-
oratively developed three chronic disease guidelines:
angina, asthma and hypertension. This consisted 
of, firstly, acquiring the knowledge and, secondly,
encoding the clinical content of the guideline into 
a computer-interpretable form so that it can be
delivered as decision support within the user’s clinical
computer system.
Knowledge acquisition is the identification, collection
and appraisal of source evidence. In Phase 3, we 
used existing peer-reviewed, paper-based guidelines.
Encoding consisted of analysing the source guideline
to identify:
 scenarios
 all possible actions, e.g. prescribing, investigations,
referral, advice and so on
 concepts that the guideline needs to be aware of,
e.g. co-morbidities, patient populations, risk factors
and so on; these form the basis of criteria that affect
the presence or preference of possible actions.
Each element is then represented within Protégé and
populated with information, such as logical criteria to
determine preference, help texts and so on. As the en-
coding process proceeded, each guideline was tested
using a prototype user interface that facilitated quality
assurance. Although the source guidelines are used 
as the source evidence for the exercise, and are often
thought of as being ‘complete’, there were many occas-
ions where we had to disambiguate statements that
were made. In addition, we had to supplement the
guidelines with other sources of information.
Knowledge re-use
This takes three main forms in the PRODIGY
programme.
Re-using knowledge from Release 1
in future models, e.g. Release 2
There are several reasons why it is desirable to migrate
knowledge between different guideline models:
 to avoid wastage of resource on re-representation of
knowledge 
 to develop and demonstrate a sharable methodology 
 to minimise work for clinical system suppliers
 to maximise the exposure of content to users of new
and legacy systems.
To this end, we analysed the structures of the two
models to identify commonality. The working hypoth-
esis was that we could partially automate the con-
version of Release 1 content into the Release 2 model.
The first step was to identify equivalent elements in
the models. Those items that were deemed equivalent
were flagged to be automatically transferred to create
an instance of the class to which they belonged. Any
elements that were not equivalent were analysed to
determine whether they could populate any element
in the new model. In fact no element in Release 1 was
redundant. Examples of the process of determining
equivalence are shown in Box 1.
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Box 1 Equivalent elements in PRODIGY
Guideline level
Background texts (R1) ® Reference document (R2)
Sex and age range (R1) ® Eligibility criteria (R2)
Scenario level
Which therapy text (R1) ® Scenario Quick help (R2)
Sex and age range (R1) ® Precondition (R2)
Action level
Therapy group (R1) ® Action step (R2)
Prescription level
Therapy detail (R1) ® Prescribable item (R2)
R1 – Release 1, R2 – Release 2
Sharing knowledge across 
and within guidelines
Knowledge re-use within and across guidelines is
being explored within the current research activity.
In Release 1 there was very little re-use. In the new
model, the design allows for re-use of elements such
as actions or sub-guidelines. For example, in the
angina guideline, wherever it is appropriate to offer
the substitution of a drug, a sub-guideline is used –
this only had to be authored once. We are also work-
ing on developing common sharable ‘parts-of-
guidelines’ or ‘guide-lets’ that could be deployed in
any guideline that required that functionality, such as
angina, hyperlipidaemia and obesity, which may all
require the availability of a lipid screening ‘guide-let’.
Development of related projects that
will link to PRODIGY guidelines, e.g.
primary care drug dictionary and
drug ontology
Currently, drug information is authored for each
guideline with only minor re-use. The drug ontology/
dictionary will provide significant proportions of
drug content for the guidelines and ensure accuracy
and consistency.
Discussion
We have described the process of taking clinical
evidence within a guideline, encoding it, making it
available to clinicians and achieving a degree of know-
ledge re-use. The likelihood of success can be increased
by improving the accuracy of conveying intended
meaning, and by achieving scalability.
Conveying intended meaning
This process needs accurately to convey the meaning
of the original clinical recommendation. Ideally the
‘encoder’ should not have to interpret the meaning of
any terms or concepts that the guideline contains –
any disambiguation that is required will require extra
resource and may alter the intended meaning. The
problem arises out of the need for the encoder to
make the concepts computable; for example, the term
‘eating disorder’ may be suggested as a concept in a
guideline, but if this is an eligibility criterion for the
guideline, then this needs to be interpreted: does it
mean all eating disorders or specific ones? This is 
not just a computability issue; the clinician who uses 
the guideline would also have to attempt to guess the
intended meaning. Therefore, we require guideline
developers to be much more explicit in the terms that
they use. In PRODIGY we have also internalised the
clinical guidance development process, and conse-
quently can be closely involved in getting the clinical
authors to be explicit in conveying the meaning of
their guidance. There is also a requirement to provide
sufficient detail for the encoding process. To this end,
work is progressing within the HL7 (Health Level 7)
framework to develop architectures for guidelines,
one benefit of which will be to specify levels of detail
and reduce errors of omission and ambiguity.11
Achieving scalability
The process needs to be scalable. There are several
factors that govern scalability; the main ones are:
the provision of authoring tools that can be used by
‘ordinary’ clinicians who can be rapidly trained in the
skills to encode clinical guidelines into a computer-
interpretable format, and the optimisation of the
management of knowledge within and across guide-
lines and guideline representation models to achieve
significant degrees of re-use. As part of this we are also
exploring the possibility of authoring knowledge
content in Release 2 format and ‘backwardly popu-
lating’ Release 1. This would mean we could continue
to implement PRODIGY in two different formats –
supporting users of new systems and users of legacy
systems – whilst minimising the additional workload
in authoring and in supplier implementation.
Acquiring and representing knowledge is a difficult
and time-consuming task. It also remains a major 
cost in developing a guideline-based decision-support
system. The proposed developments would go a long
way to improve the situation.
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